Validación preclínica y transferencia tecnológica de nanoconjugados para terapias de reemplazo enzimático de nueva generación dirigidas a enfermedades raras
Principal Investigator:
Marta Martinez-Vicente
Collaborators: Julia Lorenzo (UAB)
Agency: Ministerio de Ciencia, Innovación y Universidades (Spain)
Funding:
Type of funding: Public
Funding origin: National
Period: 2026 - 2027
Innovació en Envelliment Saludable i Malalties Neurodegenerative (NEUROAGE)
Principal Investigator:
Rafael Navajo Garrido
Collaborators: Miquel Vila, Jordi Bové, Marta Martinez-Vicente, Ariadna Laguna, Jorge Hernández-Vara
Agency: AGAUR (Spain)
Funding: 872 050 €
Type of funding: Public
Funding origin: National
Period: 2025 - 2028
Pathogenic interplay between age-dependent neuromelanin accumulation and Parkinson’s disease susceptibility factors: role in the onset and progression of the disease (NeuromelaninPD)
Principal Investigator:
Miquel Vila
Agency: Spanish Ministry of Science and Innovation (Spain)
Funding: 337 500 €
Type of funding: Public
Funding origin: National
Period: 2025 - 2028
Neuromelanin and PD: mechanisms and therapeutic perspectives
Principal Investigator:
Miquel Vila
Agency: The Michael J Fox Foundation for Parkinson's Research (USA)
Funding: 500 000 USD
Type of funding: Private
Funding origin: International
Period: 2025 - 2028
Validació funcional d’una nova teràpia intravenosa de reemplaçament enzimàtic per a malalties lisosomals amb afectació sistèmica i cerebral (SLT041/25/000039)
Principal Investigator:
Marta Martinez-Vicente
Agency: PERIS (Spain)
Funding: 148 830 €
Type of funding: Public
Funding origin: National
Period: 2025 - 2027
GBA1 Consortium: Joint Analysis to Inform Clinical Trials (MJFF-025301)
Principal Investigator:
Kathrin Brockmann (Germany)
Collaborators: Marta Martinez-Vicente, Ariadna Laguna, Jorge Hernandez-Vara
Agency: The Michael J Fox Foundation for Parkinson's Research (USA)
Funding: 1 304 737 USD
Type of funding: Private
Funding origin: International
Period: 2025 - 2027
Gastrointestinal dysfunction, inflammation and synuclein pathology in Parkinson’s disease patients: potential for diagnostic and therapeutic development (PI24/00253)
Principal Investigator:
Ariadna Laguna
Agency: Instituto de Salud Carlos III (Spain)
Funding: 265 000 €
Type of funding: Public
Funding origin: National
Period: 2025 - 2027
Evaluación del impacto social del programa PAIR: uniendo adolescentes y personas con Parkinson (CX24-00187)
Principal Investigator:
Ariadna Laguna
Agency: La Caixa Banking Foundation (Spain)
Funding: 90 000 €
Type of funding: Private
Funding origin: National
Period: 2025 - 2027
CD8 T cells and infections of the nervous system as initiators and propagators of Parkinson’s disease: towards patient stratification based on peripheral tissue biopsies
Principal Investigator:
Jordi Bové
Collaborators: Oriol De Fabregues
Agency: Instituto de Salud Carlos III (Spain)
Funding: 221 250 €
Type of funding: Public
Funding origin: National
Period: 2025 - 2027
Avanzando en el manejo de la Enfermedad de Parkinson: abordando la disfunción autofágica-lisosomal para el desarrollo de herramientas innovadoras de diagnósticos y terapéuticas (PI24/00062)
Principal Investigator:
Marta Martinez-Vicente
Collaborators: Jorge Hernández Vara
Agency: Instituto de Salud Carlos III (Spain)
Funding: 265 000 €
Type of funding: Public
Funding origin: National
Period: 2025 - 2027
